Eurocine Vaccines operates in the pharmaceutical industry with a focus on developing vaccines for the global market. The company develops vaccine candidates from early innovation and licenses them to partners for further development and commercialization. The activities are carried out in the bioscience cluster at Karolinska Institutet in Solna, Sweden.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.016
%
-1,86%
Latest
0.844
High
0.85
Low
0.754
Volume
6 540
Turnover (SEK)
5 414
Market Value (MSEK)
23,5
Time (Latest trade)
2022-11-30 09:31

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Emanuele Montomoli
  • Hans Arwidsson
  • Jan Sandström
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 28,71 28,71 2022-11-03
Avanza Pension 5,14 5,14 2022-09-28
Nordnet Pensionsförsäkring 2,73 2,73 2022-09-28
Fredrik Zachrisson 1,44 1,44 2022-09-28
Göran Erlandsson 1,28 1,28 2022-09-28
Kent Olsson 1,19 1,19 2022-09-28
Alma Westfahl 1,14 1,14 2022-09-28
Johann Bech Vedsmand 0,92 0,92 2022-09-28
Mats Kenneth Pettersson 0,92 0,92 2022-09-28
Bo Sjögren 0,86 0,86 2022-09-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-12-21 Årsstämma 2022